<?xml version="1.0" encoding="UTF-8"?>
<p id="p0155">An important consideration is the risk of prolonged hypogammaglobulinemia, especially with repeated courses of rituximab.
 <xref rid="bib65" ref-type="bibr">
  <sup>65</sup>
 </xref> Cases characterized in the literature reveal an increased risk of URIs, pneumonias, and viral infections, including fatal instances of enteroviral meningoencephalitis.
 <xref rid="bib66" ref-type="bibr">
  <sup>66</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib67" ref-type="bibr">
  <sup>67</sup>
 </xref>
</p>
